|
1
|
Bosch FX, Ribes J, Díaz M and Cléries R:
Primary liver cancer: worldwide incidence and trends.
Gastroenterology. 127(Suppl 1): S5–S16. 2004.
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108.
2005.
|
|
3
|
Roberts LR: Sorafenib in liver cancer -
just the beginning. N Engl J Med. 359:420–422. 2008.
|
|
4
|
Hall AJ and Wild CP: Liver cancer in low
and middle income countries. BMJ. 326:994–995. 2003.
|
|
5
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007.
|
|
6
|
Diasio RB and Johnson MR: The role of
pharmacogenetics and pharmacogenomics in cancer chemotherapy with
5-fluorouracil. Pharmacology. 61:199–203. 2000.
|
|
7
|
Wang H, Jiang H, Zhou M, et al: Epidermal
growth factor receptor vIII enhances tumorigenicity and resistance
to 5-fluorouracil in human hepatocellular carcinoma. Cancer Lett.
279:30–38. 2009.
|
|
8
|
Lin YJ, Hou YC, Lin CH, Hsu YA, Sheu JJ,
Lai CH, Chen BH, Lee Chao PD, Wan L and Tsai FJ: Puerariae radix
isoflavones and their metabolites inhibit growth and induce
apoptosis in breast cancer cells. Biochem Biophys Res Commun.
378:683–688. 2009.
|
|
9
|
Yanagihara K, Ito A, Toge T and Numoto M:
Antiproliferative effects of isoflavones on human cancer cell lines
established from the gastrointestinal tract. Cancer Res.
53:5815–5821. 1993.
|
|
10
|
Jun M, Hong J, Jeong WS and Ho CT:
Suppression of arachidonic acid metabolism and nitric oxide
formation by kudzu isoflavones in murine macrophages. Mol Nutr Food
Res. 49:1154–1159. 2005.
|
|
11
|
Wang Li, Wei PK, Qin ZF, Xu YP, Lou LG, Li
YL and He Ji: Experimental study on puerarin injection reverse
multidrug resistance of nude mice of human gastric carcinoma
constructed using orthotopic transplantation. J Chendu Univ Tradit
Chin Med. 1:42–44; discussion 46, 2005 (In Chinese).
|
|
12
|
Yu Z and Li W: Induction of apoptosis by
puerarin in colon cancer HT-29 cells. Cancer Lett. 238:53–60.
2006.
|
|
13
|
Han P, Pei LY, Li J, Zhang L, Zhang HQ and
Xu D: Effect and mechanism of pueraria crude extract puerarin on
lung cancer H446 cell proliferation. Shandong Med J. 48:7–9.
2008.(In Chinese).
|
|
14
|
Hien TT, Kim HG, Han EH, Kang KW and Jeong
HG: Molecular mechanism of suppression of MDR1 by puerarin from
Pueraria lobata via NF-kappaB pathway and cAMP-responsive
element transcriptional activity-dependent up-regulation of
AMP-activated protein kinase in breast cancer MCF-7/adr cells. Mol
Nutr Food Res. 54:918–928. 2010.
|
|
15
|
Li XR, Zhang QQ, Cui YH, Hua QL and Yang
T: The growth influence on human esophageal cancer cells EC9706
induced by puerari. XIan Dai Zhang Liu Yi Xue. 10:1922–1924.
2010.
|
|
16
|
Jing XF, Li H and Li XM: Effect of
puerarin on AQP 1 mRNA expression level in esophageal cancer cell
line TE-1 and ECA109. Xinjiang J Med Univ. 34:258–260. 2011.(In
Chinese).
|
|
17
|
Tan GS, Sun L and Cao JG: Cytotoxic
constituents from Bulbuphyllum inconsipicum. You Ji Hua Xue.
3:372–374. 2006.(In Chinese).
|
|
18
|
Chou TC and Talalay P: Quantitative
analysis of dose-effect relationships: the combined effects of
multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55.
1984.
|
|
19
|
Chou TC, Motzer RJ, Tong Y and Bosl GJ:
Computerized quantitation of synergism and antagonism of taxol,
topotecan, and cisplatin against human teratocarcinoma cell growth:
a rational approach to clinical protocol design. J Natl Cancer
Inst. 86:1517–1524. 1994.
|
|
20
|
Kim BR, Shim JW, Sung DK, et al:
Granulocyte stimulating factor attenuates hypoxic-ischemic brain
injury by inhibiting apoptosis in neonatal rats. Yonsei Med J.
49:836–842. 2008.
|
|
21
|
Guide for the Care and Use of Laboratory
Animals. National Research Council (US) Committee for the Update of
the Guide for the Care and Use of Laboratory Animals. 8th edition.
National Academies Press; Washington (DC): 2011
|
|
22
|
Awad ME, Abdel-Rahman MS and Hassan SA:
Acrylamide toxicity in isolated rat hepatocytes. Toxicol In Vitro.
12:699–704. 1998.
|
|
23
|
Huang XW, Tang ZY, Lawrence TS and Zhang
M: 5-fluorouracil and hydroxyurea enhance adenovirus-mediated
transgene expression in colon and hepatocellular carcinoma cells. J
Cancer Res Clin Oncol. 131:184–190. 2005.
|
|
24
|
Siddik ZH: Cisplatin: mode of cytotoxic
action and molecular basis of resistance. Oncogene. 22:7265–7279.
2003.
|
